Detalhe da pesquisa
1.
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes.
Diabetol Metab Syndr
; 15(1): 160, 2023 Jul 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37468901
2.
Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus.
Diabetol Metab Syndr
; 12: 45, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32489427
3.
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM).
Diabetol Metab Syndr
; 9: 53, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28725272
4.
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM)
Diabetol. metab. syndr
; Jul(9): 9-53, 2017. tab
Artigo
Inglês
| SES-SP, SES SP - Instituto Dante Pazzanese de Cardiologia, SES-SP | ID: biblio-1062397
5.
Diretriz brasileira baseada em evidências sobre prevenção de doenças cardiovasculares em pacientes com diabetes: posicionamento da Sociedade Brasileira de Diabetes (SBD), da Sociedade Brasileira de Cardiologia (SBC) e da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) / Brazilian evidence-based guideline on cardiovascular disease prevention in patients with diabetes: positioning of the Brazilian Society of Diabetes (SBD), the Brazilian Society of Cardiology (SBC) and the Brazilian Society of Endocrinology and Metabology (SBEM)
Arq. bras. cardiol
; 109(6,supl.1): 1-31, dez. 2017. tab
Artigo
Português
| LILACS | ID: biblio-887990